Betamethasone (1 brand name, 3 dosage forms, 2 routes)
Available dosage forms: CREAM, TABLET, SYRUP.
Routes of administration: TOPICAL, ORAL.
Brand Names
- CELESTONE
Indications and Usage
ATTERO™ Topical Suspension is indicated for the topical treatment of plaque psoriasis of the scalp in patients 12 years and older and plaque psoriasis of the scalp and body in patients 18 years and older. Additional pediatric use information is approved for LEO Pharma A/S’s Taclonex® (calcipotriene and betamethasone dipropionate) Topical Suspension. However, due to LEO Pharma A/S’s marketing exclusivity rights, this drug product is not labeled with that information.
Dosage and Administration
Instruct patients to shake bottle prior to using ATTERO™ Topical Suspension. Apply ATTERO™ Topical Suspension to affected areas on the scalp and body once daily for up to 8 weeks. ATTERO™ Topical Suspension should be discontinued when control is achieved. Instruct patients to wash their hands after applying the product. Inform patients that they should not take a bath or shower or wash their hair right after application of ATTERO™ Topical Suspension. Patients 12 to 17 years should not use more than 60 grams per week and patients 18 years and older should not use more than 100 grams per week. ATTERO™ Topical Suspension should not be: Used with occlusive dressings unless directed by a healthcare provider. Used on the face, groin, or axillae, or if skin atrophy is present at the treatment site. Applied to the scalp in the 12 hours before or after any chemical treatments to the hair. ATTERO™ Topical Suspension is not for oral, ophthalmic, or intravaginal use.
Contraindications
None.
Mechanism of Action
ATTERO™ Topical Suspension combines the pharmacological effects of calcipotriene as a synthetic vitamin D3 analog and betamethasone dipropionate as a synthetic corticosteroid. However, while their pharmacologic and clinical effects are known, the exact mechanisms of their actions in the treatment of plaque psoriasis of the scalp and body are unknown.